As of Oct 24
| +0.06 / +3.95%|
The 7 analysts offering 12-month price forecasts for Novavax Inc have a median target of 2.00, with a high estimate of 14.15 and a low estimate of 1.00. The median estimate represents a +26.58% increase from the last price of 1.58.
The current consensus among 8 polled investment analysts is to Hold stock in Novavax Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.